PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
8215470-3	1993	PLC/PRF/5 cells were most effectively killed by cisplatin and etoposide, HuH-7 cells by cisplatin and carboplatin, HuH-6 cells by etoposide, and Hep G2 cells by cisplatin.	Etoposide	62-71	heparan sulfate proteoglycan 2	Homo sapiens	0-3	
23093908-3	2012	METHODS: Using a stable Bid-overexpression HCC cell line, Bid/PLC/PRF/5, overexpression of Bid promoted loss of viability in response to etoposide-induced DNA damage.	Etoposide	137-146	heparan sulfate proteoglycan 2	Homo sapiens	62-65	
23093908-6	2012	RESULTS: The survival rates of 100 muM etoposide on the cells with control vector and Bid/PLC/PRF/5 at 48 hours amounted to 71% +- 0.75% and 59% +- 0.60% with MTT assay, and similar results of 85% +- 0.08% and 63% +- 0.14% with BrdU-labeling assay respectively.	Etoposide	39-48	heparan sulfate proteoglycan 2	Homo sapiens	90-93	
7750085-1	1995	Anticancer drugs etoposide and mitomycin C increased nuclear p53 protein and decreased proliferating cell nuclear antigen (PCNA) of PLC/PRF/5 human hepatoma cells.	Etoposide	17-26	heparan sulfate proteoglycan 2	Homo sapiens	132-135	
12700406-6	2003	Our results revealed a strong linear negative correlation between basal MT levels and etoposide-induced apoptosis in the human tumor cell lines PLC/PRF/5, H460, and HepG2 (r = -0.991).	Etoposide	86-95	heparan sulfate proteoglycan 2	Homo sapiens	144-147	
8215470-3	1993	PLC/PRF/5 cells were most effectively killed by cisplatin and etoposide, HuH-7 cells by cisplatin and carboplatin, HuH-6 cells by etoposide, and Hep G2 cells by cisplatin.	Etoposide	130-139	heparan sulfate proteoglycan 2	Homo sapiens	0-3	
8215470-6	1993	Combined treatment with cisplatin (0.01-1.0 microgram/ml) and etoposide (0.1 microgram/ml) showed synergistic cytotoxic effects on the colony formation of PLC/PRF/5 cells, while combination of carboplatin (0.01-0.1 microgram/ml) and etoposide (0.1 microgram/ml) caused subadditive cytotoxic effects.	Etoposide	62-71	heparan sulfate proteoglycan 2	Homo sapiens	155-158	
8215470-6	1993	Combined treatment with cisplatin (0.01-1.0 microgram/ml) and etoposide (0.1 microgram/ml) showed synergistic cytotoxic effects on the colony formation of PLC/PRF/5 cells, while combination of carboplatin (0.01-0.1 microgram/ml) and etoposide (0.1 microgram/ml) caused subadditive cytotoxic effects.	Etoposide	233-242	heparan sulfate proteoglycan 2	Homo sapiens	155-158